The area of biomedical imaging is fast becoming an active focus for the utilisation of graphene within a variety of imaging modalities. Graphene can be oxidised to produce a material with a high degree of functionality and has led to its expansion as a platform for the immobilisation of fluorescent and radiolabelled molecules. Its large surface area has allowed graphene and its oxides to be modified with a variety of molecules that enhance biocompatibility, selectivity and therapeutic potential. This chapter highlights recent developments in the use of targeted fluorogenic or radiolabelled graphene materials that can be used to image cancers via fluorescence, PET & SPECT modalities. Key emphasis is placed on the nanocomposites that are designed to provide additional therapeutic effects. The capacity of these composites to be internalised by cells and tumours is discussed to appreciate the future perspective of graphene and its congeners as therapeutic multimodal imaging agents.
One of the main reasons behind this increase in diagnosis is due to modern screening and imaging technologies, such as magnetic resonance imaging (MRI) and commuted tomography (CT) methods, which have allowed physicians to expose cases of cancer that would have previously remained undiagnosed. The other one is an ever ageing population that has made it necessary to anticipate further rises in cancer incidence that require broad and robust screening technologies in order to inform and assist medical professionals and their patients across the entire spectrum of cancer developments and treatments. Cancer is an extremely complex degenerative condition, whereby each type of cancer is biologically different from another.
Depending on the cell origin and the extent of mutagen exposure, certain cancers will demonstrate varying propensities for proliferation. 2 For instance, cancers can differ in terms of their tissue origin, with sarcomas arising from connective tissue or muscle, whereas carcinomas come from epithelial cells. Each of these cancers can have a wide array of contributory genetic abnormalities that can influence the overall nature of the cancer malignancy. These factors make it difficult to identify the way the particular cancer cells are behaving and how they are likely to metastasize or damage the body. Without a full understanding of the physiology of the cancer, effective treatments remain elusive to develop. The highly individualised nature of cancer development and wide variation in tumour heterogeneity 3 has led to the acknowledgment that an accurate determination of an individual's specific state of cancer progression will allow clinicians to tailor their treatments to suit a particular patient's needs.
This will aid in achieving a more personalised approach towards the therapy and diagnosis of cancer.
This is the primary principle of theranostics development whereby screening and diagnosis methodologies simultaneously incorporate therapeutic strategies in order to achieve a more rapid and efficient cancer diagnosis and treatment protocol. 4 MRI techniques have proven to be a quite effective method in cancer diagnosis due to its ability to provide detailed images of tissue and organs in a comparatively non-invasive manner. 5 There is a relatively minimal risk to patients associated with use of the MRI contrast agent gadolinium chelate. 6 However, despite its accuracy and considerable versatility with respect to identifying instances of cancer, it presents a very low sensitivity and there are still issues associated with incidental findings that can complicate the interpretation of resulting images. In addition, to date there are no instances of incorporating simultaneous therapeutic strategies within MRI imaging. On the other hand, it has become necessary to look to alternative imaging techniques and broaden the scope of molecules that have the capacity to not only screen and diagnose, but to also treat cancer to ultimately achieve the theranostics' goals.
Amongst the many several imaging modalities for cancer diagnosis and treatment, fluorescence imaging, Positron Emission Tomography (PET) and single photon emission computed tomography (SPECT) have garnered considerable research interest, due to the availability of a wide selection of molecules with suitable properties for providing a good signal that can be exploited to image a variety of cancers. 7 Fluorescence techniques employ a number of well-established molecules directed to target cancer specifically, such as Rhodamine, derivatives of fluorescein and more recently near-infra red emitting cyanine dyes. 8 The characteristic of these molecules to emit fluorescent and phosphorescent photons after excitation with wavelengths in the visible and near infra-red region of the spectrum has led to their conjugation to a variety of molecules in order to enhance their properties for cancer imaging and treatment. In particular, the use of near infra-red absorbing molecules has transformed the way in which cancer is visualised. Considering that large portions of tissue are transparent to near-infra red wavelengths, such fluorophores have allowed for deeper penetration into living tissue that effectively eliminates the background auto-fluorescence. Furthermore, the capacity for certain fluorophores to undergo intersystem crossing after excitation and achieve triplet excited states has led to their incorporation in simultaneous therapeutic strategies that rely on the generation of cancer targeting singlet oxygen species. 9 With respect to PET and SPECT imaging modalities, both of these techniques employ radioisotopes as a means of characterising cancers, based on the localisation of intravenously injected radiotracers. Typically, the chosen molecules are labelled with Oxygen-15, Fluorine-18, Carbon-11 and Nitrogen-13 radioisotopes. However, the broad availability of a selection of isotopes within the field of nuclear medicine has led to the development of alternative metallic based radioisotopes with considerably longer half-lives than those of the aforementioned elements. These include various metallic complexes of copper, gallium, indium and technetium amongst others. 10 Although these imaging modalities are very sensitive and quantitative, they possess a poor spatial resolution. The spatial resolution and detection capabilities of PET/SPECT imaging agents are key factors in determining their ultimate value towards cancer diagnosis. Current pre-clinical gamma detecting cameras can provide sub 0.5 mm and 1-2 mm resolution for SPECT and PET scanners respectively. Furthermore, PET/SPECT techniques are now being incorporated into dual MRI or CT systems in order to gather more information about biological systems in the same spatial temporal environment.
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The ability of imaging technologies to achieve both diagnosis and therapy is a considerable challenge that relies heavily on the capacity of the exploited molecules to express an inherent multitude of physical phenomena or to be easily conjugated to molecules that can provide the additional therapeutic effect. More commonly, the imaging strategy is used to monitor the progress or efficacy of a separately administered therapeutic strategy rather than providing the therapeutic effect as well. However, the field of biological imaging is beginning to expand into the incorporation of graphene materials to achieve just such a goal. The capacity of graphene to provide a surface area and functional group targets makes it an obvious choice for the incorporation of multiple imaging agents, as well as bio-targeting and therapeutic molecules to achieve the Theranostic goals in cancer management. This opens up the potential for graphene as an imaging and therapeutic tool via multiple modalities.
B. Probe Design towards a Solution
The development of graphene oxide based probes, with the aim of achieving imaging via multiple modalities as well as additional therapeutic effects, requires a multifaceted approach to imaging and diagnostic probes' design. A careful selection of molecules exhibiting the appropriate characteristics for imaging via fluorescence, PET and SPECT is required. The chosen molecule will ultimately determine the method of immobilisation onto graphene oxide, whether it be a covalent or non-covalent strategy. For instance, numerous fluorophore compounds make use of the presence of π conjugation within their structures to attach to graphene through π-π interactions. Additionally, pre-derivatisation of the fluorophore with a biomolecule can eliminate the need for multiple conjugation strategies. In some cases, the strategy involves exploiting the varied charged nature of biomolecules to immobilise them via electrostatics separately. Quite frequently, fluorophores and biomolecules are covalently immobilised via peripheral carboxylic acid groups, which are introduced to graphene after oxidation. Among these molecules that possess fluorescence characteristics, varieties of them contain or can be synthesised to contain metals used in PET/SPECT based imaging modalities. 24 Considerable bodies of work are also dedicated to labelling biomolecules with radioisotopes, with the modification of peptide sequences with technetium proving to be an active area of research. With respect to fluorophore attachment to a graphene-based scaffold, a number of studies has exploited the tendency of graphene to act as an efficient quencher of fluorescence via Forster Resonance Energy Transfer (FRET). Some of these fluorophores may also demonstrate the ability to achieve triplet excited states. 26 These two phenomena make graphene a potential candidate for the facilitation of photodynamic and photothermal therapeutic effects. 27 Multimodal imaging and therapeutic intentions require key design features to be met if a viable imaging agent is to be achieved. 
Facile and rapid routes to functionalising graphene oxide for biomedical applications
Having established the presence of a variety of oxygen functional groups on GO, the material naturally becomes a promising candidate for various chemical functionalisations that would render it a far more valuable material for biomedical imaging and sensing applications.
Carboxylic acid activation
When considering the use of carboxylic acid groups as targets for functionalisation it is necessary to use an appropriate activating agent. Thionyl Chloride, 45 EDC (EDC = 1-Ethyl-3- The primary concern with the use of this reagent is the potential for self-polymerisation in which the bio-molecule may react with another molecule of itself due to the presence of carboxylates and amines.
Studies have been performed whereby carbodiimide activation approaches have been used to modify GO sheets with polyethylene glycol (PEG) as a means of developing a biocompatible drug delivery vector/vehicle for anti-cancer drugs. 49 In this study in vitro tests were carried out in which it could be to demonstrate that the covalently functionalised GO served as a viable vector for the immobilisation of anticancer drugs via π-π stacking. The GO hybrid material was ultimately shown to possess a high performance towards the killing of human colon cancer cells.
Carboxylic activation methods have also been used for the covalent attachment of porphyrins to GO as a means of developing light harvesting materials for photovoltaic applications. 50 The overall broad applicability of carboxylic activation via carbodiimide mediated or alternative activation approaches demonstrates the suitability of these reagents for the development of zero length cross-linkers for fluorescent and bio-electronic applications.
Epoxide ring opening reactions
As discussed earlier, a significant number of structural models based on infra-red spectroscopic studies and solid state NMR investigations have suggested the existence of epoxy groups distributed along the basal plane of the graphitic domains. These are in a greater abundance with respect to the carboxylic acids and therefore present another attractive area for molecular functionalization. 34 In 2011, one study utilised an epoxide ring opening strategy with an amine containing ionic liquid in order to provide a suitably positive electrostatic charge for the immobilisation of a glucose oxidase enzyme. 51 A relatively simple methodology in which the ionic liquid [1-(3-aminopropyl)-3-methylimidazolium bromide] (NH2-IL) was added to a GO dispersion along with potassium hydroxide and with 24 hours of stirring overnight, led to the subsequent immobilisation of glucose oxidase into the IL-graphene surface. Ring opening strategies have also been used to impart photoluminescent properties onto graphene oxide. 52 In this work alkylamines of varying chain length were used to remove the opportunity of recombination of electron-hole pairs as a result of the presence of both epoxy and carboxylic acid groups, which is largely seen as the reason for the lack of strong fluorescence emission characteristics in GO. 53 Acylation reactions to form surface amides followed by nucleophilic ring opening aminations lead to the removal of both the carboxylic acid and epoxy groups, which in turn greatly enhanced the fluorescent quantum yields of GO.
Non-covalent tagging strategies
The extensive sp 2 hybridisation of the planar graphitic domains opens up the opportunity for functionalisation via π-π stacking or van der Waals forces in the areas that lack the oxygen functionality or hydrogen bonds.
Hunter and Sanders have described a model for understanding the interaction between separate aromatic systems. In general, the electron density derived from the π orbitals of aromatic rings creates a quadrupole moment possessing an overall partial negative and partial positive charge on top of aromatic faces and on the periphery respectively. When these moments come within a suitable distance, a face centred parallel stacking interaction can occur. 54 The interaction between aromatic molecules that alternate in their extent of electron density is sometimes referred to as aromatic donor-acceptor interactions. Although there is still considerable debate in regards to the driving forces behind the interactions between aromatic molecules in close proximity to one another, 55 it would still suffice to conclude that such interactions present an attractive strategy towards the construction of supramolecular assemblies based on aromatic graphitic and fluorescent bio-molecules.
We have recently focused our research work on non-covalent strategies to functionalise the surface of GO with aromatic chromophores in particular with aryl thioacetate Zn(II) porphyrin. 56 Cells were incubated with the GO conjugates, along with a number of endocytosis inhibitors in order to understand the pathways that influence the migration of GO into cells. They were able to show that micropinocytosis is the most prevalent means of uptake. Macropinocyctosis is a process in which a fluid containing vesicle, known as a micropinosome, breaks away from the cell surface and incorporates the material in question. 57 The micropinosome along with its cargo is subsequently drawn into the interior of the cell. In addition to micropinocytosis, phagocytosis, microtubule and clathrin dependent mechanisms can also play a role in graphene endocytosis.
Ultimately this study showed that there is a general method of cellular internalisation; however, there can be additional mechanistic pathways depending on the cell type.
Nano-graphene oxide, i.e. a graphene oxide whose 3 dimensions are under 100 nm, has been reported as a viable facilitator of drug delivery and cellular imaging applications. In 2008, a study was carried out in which PEGylated nano-graphene oxide was used to image cells and deliver anti-cancer drugs. The GO materials that possessed fluorescent properties in the visible and near-infra red region were used to selectively image Raji-B cells via the detection of near infra-red photoluminescence. 58 Furthermore, the physical adsorption of the anti-cancer drug doxorubicin via π-π interactions onto the nano graphene oxide with a cancer targeting antibody
Rituxan was able to facilitate the selective killing of specific carcinoma in vitro.
In summary, GO presents a number of options for functionalisation via various covalent and supramolecular interactions. The broad applicability of the resulting nano-materials from fluorescent materials, drug delivery vectors, electrochemical through to light harvesting applications enhances its viability as a candidate for the development of multifunctional imaging and therapeutic tools that exploit optical transduction methodologies.
a PEGylation is the process of both covalent and non-covalent attachment or amalgamation of polyethylene glycol (PEG) polymer chains to molecules and macrostructures, such as a drug, therapeutic protein or vesicle, which is then described as PEGylated
B. Fluorescence imaging and therapeutic applications of functional Graphene Oxide-based probes
A fluorescent probe is a compound that possesses an intrinsic ability to emit fluorescent photons after excitation with an appropriate wavelength. Upon conjugation to a biomolecule via a reactive site on the fluorophore, the resulting modified biomolecule can be suitable for applications such as imaging and fluorescent based biosensors. Labelling biomolecules with fluorescent compounds is seen as an attractive option for the aforementioned applications because of their highly specific emission characteristics after excitation with light. 59 The processes that occur in fluorescence during the absorption and emission of light can be illustrated by the Jablonski diagram ( Figure 7 ). The initial transition denoted in the Jablonski diagram is the process of photon absorbance.
During this event a photon of a specific energy is excited from a lower ground energy level to a higher energy state. The photonic energy is transferred to an electron, which then excites to a heightened state depending on the energy transferred. The absorbance events occur quite rapidly in the region of 10 -5 seconds. 61 Once an electron has reached an excited state, the energy absorbed can be dissipated through the loss of a photon. This event is known as fluorescence and occurs at relatively slower timescales such as 10 -9 to 10 -7 seconds. Fluorescence phenomena tend to occur between the 1 st excited electron level and the ground state. At higher energies, dissipation of the absorbed energy is more likely to occur via internal conversion or vibrational relaxation. During vibrational relaxation, the energy absorbed during excitation can be given to other vibrational modes as kinetic energy. Internal conversion also occurs when vibrational energy levels overlap with electronic energy levels allowing for transitions between vibrational states of different electronic levels. 61 Finally, intersystem crossing can occur in which electrons in a singlet state transition to an excited triplet state. The transition down from an excited triplet state to a singlet ground state is responsible for phosphorescence phenomena.
It is such excited state energy transitions that allow for photodynamic therapeutic strategies or fluorescence resonance energy transfer based in vitro/vivo recognition and imaging methodologies that will be the main focus of the first section of this review. amino acids re-arrange themselves to a parallel conformation along the basal plane of the graphitic domains via π-π interactions. In addition to these theoretical studies, experimental investigations have probed the interaction of lysine, arginine, tryptophan and tyrosine with GO.
They have also concluded that binding between amino acids and GO can be considerably influenced by π-π interactions. However, they also suggest that the positively charged side chains on lysine, histidine and arginine can bind to GO via additional electrostatic mechanisms.
In general a large majority of studies associated with experimental and atomistic investigations have implicated the amino acid residues such as tryptophan as being the strong driving force behind the immobilisation of peptides to graphene and carbon nanotube surfaces. 
D. Targeted Fluorescent Molecules anchored onto Graphene Oxide for Cancer

Imaging and Therapy Applications
Graphene has demonstrated a capacity to serve as an imaging, diagnostic and therapeutic platform in a variety of functional states. In some instances, it can be used in conjunction with other nanoparticles to form effective diagnostic tools. In 2014, Ji et al. developed a prognostic indicator for early-stage cancer based on a combined graphene-mesoporous silica nano-sheet. 75 The value of such a system with respect to the in situ detection of prognostically significant bio-markers was fully realised after assembling the graphene-silica (GS) platform with a polyethylene glycol derivatised hexapeptide (PEG-RWIMYF) that served as recognition mechanism cyclin A2 ( Figure 10 ). This particular cyclin has been implicated in the deregulation of cyclin dependant kinase (CDK) activity and hence chromosomal instability and ultimately tumour proliferation. 44 Initially, the GS surface was functionalised with amines which were then converted to carboxyls (COO-) to allow for the electrostatic capping adsorption of the positively charged peptide. Prior to this step, the mesoporous silica had been loaded with Rhodamine B.
Upon specific binding to cyclin A2, the peptide capping agent was removed from the GS nano-surface allowing for the release of Rhodamine B, effectively acting as a turn on switch for the quenched fluorescence. The tendency for graphene to act as an effective quencher, as well as its capacity to be functionalised to facilitate physisorption, allowed for the efficient intracellular delivery of the fluorescence based recognition imaging agent. This particular functional nano-system was able to demonstrate the in vitro concentration dependant detection of cyclin A2 in a variety of cancerous and healthy cell lines based on the observed fluorescence intensity. Furthermore, the probe could be used to monitor the efficacy of the anti-cancer drug doxorubicin (DOX). DOX is known to up-regulate the expression level of cyclin A2. Consequently, in cell lines that were treated with DOX a corresponding increase in situ fluorescence was observed.
This multicomponent approach to graphene probe design is one example of how incorporating peptides and fluorophores opens up the opportunity to exploit cellular recognition mechanisms to not only image and detect diagnostically relevant biomarkers, but to also track the progress of therapeutic strategies.
One of the more widely researched biomarkers for the screening of prostate cancer is Prostate Specific Antigen (PSA). PSA is a serine protease that is produced by both prostate carcinoma, as well as their healthy or benign counterparts. Currently, there is still a great deal of limitation associated with PSA diagnostic measures in that they regularly fail to provide a suitable degree of specificity with respect to identifying and distinguishing between prostate cancers based on their malignancy. 76 The proteolytic active form of PSA has been shown to be a more effective discriminator of prostate cancers based on their metastatic potential. 77 This has led to the development of fluorescence based peptide targeting methods that can facilitate the "on-off" switching signal for this particular active form of PSA. Feng et al. developed an imaging based sensing probe through the modification of GO via peptide derivatised fluorescein isothiocyanate. 78 The peptide containing the sequence HSSKLQ c has been shown to be selectively cleaved by the proteolytic form of PSA. The construction of this sensing probe was achieved via the π-π and electrostatic interactions between peptide labelled FITC and the GO surface. As the active PSA is bound to the nano-construct, the protease would cleave the peptide allowing for the release of the dye due to diminished electrostatic interactions and hence recover the FITC fluorescence that was quenched due to the close proximity of the GO.
c A peptide sequence that is selectively cleaved by the proteolytic form of the prostate specific antigen One of the key challenges of developing Theranostic imaging agents for cancer based on GO materials is associated with enhancing the ease at which it can be dispersed in biological media. Many studies have utilised PEGylated GO to achieve just this purpose. However, the utility of dendrimer type molecules extends to not only enhancing the stability of GO dispersions, but to also providing additional functional group anchor points. Dendrimers can serve to provide a branched architecture with a variety of functional groups for the immobilisation of a number of imaging and targeting agents. 81 Wate et al. developed a GO system in which the dendrimer PAMAM G4 was used as an interface to facilitate the incorporation of a cyanine dye and magnetic Fe3O4 nanoparticles. 82 The inclusion of magnetic nanoparticles enhanced the capacity to direct the cellular localisation via the application of an external magnetic field. This work focused primarily on covalent methods to develop the nanoconstruct. Glutathione (GSH) was used as a spacer/linker molecule to attach Fe3O4 and a cyanine dye to the GO surface via EDC carbodiimide activation protocols. nanoparticles. 82 The resulting nano-construct was tested in vitro to characterise its capacity to image cells, as well as the resulting cellular viability after prolonged incubation. These tests were able to demonstrate successful uptake of the probe in MCF-7 breast cancer lines after dendrimer mediated dispersion in aqueous solution. The attachment of the cyanine dye facilitated successful NIR imaging of cells with predominant localisation within the cytoplasm. Despite the multicomponent nature of the nano-probe little to negligible cytotoxicity was observed.
The value of graphene oxide and its reduced derivatives extends beyond its capacity to be readily functionalised, in that it possesses intrinsic near infra-red absorbance properties. As alluded to in the introduction, this is of particular value with respect to imaging and therapeutic applications, primarily because the majority of living tissue is transparent to near infra-red light. Photothermal therapy relies on the capacity of the resulting heat generated from near infra-red light absorption as a means of achieving photoablation which ultimately leads to cancer cell death. 83 Therefore, if selective uptake of graphene by cancer cells and tumours can be achieved there is potential for highly efficient imaging and photothermal therapeutic strategies.
Robinson et al. employed nano-dimensional reduced graphene oxide with NIR absorbance characteristics that had been further functionalised with RGD (arginylglycylaspartic acid)
targeting peptides and an additional cyanine dye (cy5) to further enhance NIR absorption. RGD peptides are known to target αvβ3 integrins e distributed along the membrane of cancer cells. Functionalisation via the diimide nitrogens results in naphthalene derivatives possessing variable absorption and emission characteristics. Generally, the attractive optical properties can be attributed to the presence of extended aromatic π conjugated systems. NDIs free of substitution on the naphthalene core tend to absorb only in the UV region. 87 Extending the π conjugation via the addition of extra aromatic groups on the diimide nitrogens can improve absorption characteristics as is the case with perinones, which have phenylene diamine substituents on the diimide nitrogens and have been used as dyes and pigments as early as the 1950s. 88 The structure of NDIs also provides them with the ability to form supramolecular assemblies based on donor acceptor interactions. The aromatic and electron deficient characteristics render them with the ability to form face centred aromatic interactions. This particular property opens up avenues for functionalising GO via π-π stacking interactions. 
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These studies revealed the successful uptake of the NDI-peptide conjugate within the cytoplasm of the exposed cells. One of the key findings was a narrowing of the excitation wavelength of the NDI after derivatisation with cyclic RGD to a region of the spectrum that avoided interfering cellular auto fluorescence. This supports the notion that RGD based NDI fluorescent imaging probes can be used to achieve more specific tracing and characterising of αvβ3 integrin expression in vitro.
The previously mentioned dendrimer immobilisation strategy has also been used to facilitate a synergistic imaging and photothermal therapeutic effect by incorporating targeted phthalocyanine dyes onto GO surfaces. Taratula et al. utilised a polypropylene imine dendrimer to immobilise the dye molecules, PEG chains and luteinizing hormone releasing hormone (LHRH) peptide to selectively target ovarian cancer. 90 This particular design allowed for GO to demonstrate its capacity to facilitate photodynamic therapy, as well as photothermal therapy.
Near infra-red radiation of the phthalocyanine allowed for heat generation as energy transferred between the excited dye and the GO. Additionally, the dye could also achieve a triplet excited state which facilitated the formation of reactive oxygen species that created a photodynamic therapeutic effect. These combined strategies allowed for enhanced killing capability (90-95 %) at low dye and graphene concentrations. In vivo studies also confirmed the ability of the probe to image cancer tumours in mice.
The exploitation of FRET to enhance photothermal therapy via NIR dyes and GO extends to probe design with much simpler assemblies. Guo et al. conjugated the NIR dye cypate f to GO via a PEG linker. Upon irradiation of the dye, FRET induced an enhanced photothermal effect that was sensitive to pH. 91 The dye-graphene conjugate demonstrated enhanced accumulation capacity in the tumours of mice, despite no specific derivatisation of the probe with a targeting biomolecule ( Figure 17 ).
Additionally, the rapid clearance of the probe from normal tissue has also been demonstrated. In vivo studies showed remarkable tumour necrosis and regression 2 days after injection and no tumour re-growth 22 days after injection. This was not the case for control f A reactive carbocyanine dye, which is derived from indocyanine green studies performed in absence of the dye. The GO-PEG construct alone demonstrated reasonable tumour re-growth within a 22 day period post-injection. This confirmed that the effective tumour ablation was ultimately due to the photothermal therapeutic effects facilitated by the presence of the dye and its capacity to undergo FRET with GO. 10 The following section will describe some examples of how these radioisotopes can be used in conjunction with other molecules to facilitate radiolabelled tracing and imaging of cancer in vivo.
At this point it is clear that graphene possesses immense potential with respect to the immobilisation of a variety of molecules for a number of imaging and therapeutic applications.
Over recent years this has been extended to PET based imaging modalities with 66 Ga. 66 Ga is of particular interest for GO mediated PET imaging strategies due to its longer half-life (9.5 h) with respect to 68 Ga (68 min), a half-life that is relatively complimentary to the in vivo kinetics of GO. One of the more common chelators of gallium radioisotopes is 1,4,7-triaxacyclononane-1,4,7-triacetic acid (NOTA). 93 To this end, Hong et al. 94 covalently linked and amine terminated PEG for the immobilisation of 66 Ga labelled NOTA that had been previously derivatised with an antibody that targets CD105 (endoglin) expression on the endothelial cells of tumours subject to proliferation. 95 The resulting pharmacokinetics and capacity for tumour targeting was evaluated via PET imaging in mice carrying murine breast tumours ( Figure 19 ). The radiolabelled GO composite showed a rapid and stable tumour accumulation rate over the course of a 24 hour period post injection. This particular study was also able to demonstrate the suitability of the targeting agent, as histological studies showed there was no GO uptake in the tumours of mice that had been administered with the conjugate without CD105 targeting antibody. The ability to label GO with 66 Ga poses considerable opportunity for further study with respect to elucidating the long term outcome and biodistribution of GO due to its superior half-life allowing for more prolonged studies. This may provide more valuable information about the state of tumour development and hence facilitate improved imaging and therapeutic intervention.
This particular strategy towards radiolabelling has also been used to facilitate the inclusion of 64 Cu within the targeted GO-NOTA construct. 96 This immuno-construct possessing a slightly longer half-life (12.7 h) to its 66 Ga counterpart showed significant uptake within the tumours, as well as the liver spleen and intestines which is not uncommon for intravenously injected nanomaterials that are cleared through the hepatobiliary system. Ultimately, these works demonstrate that active and broad labelling of GO can be achieved with a number of radioisotopes provided there is a suitable chelator for the attachment to GO.
The capacity to radiolabel graphene has also extended to the use of 125 I isotopes in order to study the localisation and general biodistribution of graphene materials after oral administration or injection. Yang et al. used 125 I to label PEGylated nanographene oxide (nRGO-PEG). 97 The in vivo biodistribution of labelled GO variants was assessed after oral administration to mice. Considerable levels of radioactivity were observed in the stomach and intestines. However, no radioactivity was monitored in the organs of the mice one week post consumption ( Figure 21 ). The functionalization of GO can also be achieved by decorating its surface with biocompatible polymers that, although not directly involved in the imaging process, can be of great benefit to the biocompatibility, distribution and excretion of the probe. The intrinsic aromatic nature of GO can also be used to simplify the chemistry of surface functionalization.
Indeed, a great variety of organic molecules, including fluorophores, can self-assemble around GO sheets by virtue of π-π stacking or van der Waals forces to generate supramolecular adducts. The intrinsic near infra-red absorbance properties of GO make this derivative of carbon one of the materials of choice for optical microscopy and imaging. Moreover, the tissue distribution and excretion of chemically functionalised GO have been recently explored and discussed. 102 The work of Bianco and Kostarelos have demonstrated that particular derivatives of GO undergo rapid and significant urine excretion. This work will surely have significant implications for the use of GO in vivo and for general medical treatments. Much remains to be developed in the use of GO and carbon allotropes in the context of screening and tumour therapy but it is undisputable that much progress will be achieved considering the growing interest that GO is generating within the scientific community.
